There are 1,492 papers on MTOR in aging research: 63 trials and 63 observational studies in people, 775 in animals, 220 in cells, 342 reviews.
26 new papers in 30 daysSee all 1,492 papers on MTOR
At a glance
Hypomorphic MTOR alleles extend mouse lifespan, while MTOR overexpression extends lifespan in CG7156-knockdown flies. Independent labs reproduce mTOR-driven senescence in human cells and reduced mTOR signaling with caloric restriction in mice, though restriction results also point the other way. Some registered trials across its uses remain without posted results or citing papers over a year after ending.
186 findings in 148 papers from 2009 to 2026, 13 of them since April 2026
Independent labs found the same change in cells, worms or flies, mice and people. 273 independent labs in 41 countries; 107 trials, 28 with no results posted.
“by immunohistochemical analysis, we documented altered expression of mTOR and its well-characterized downstream substrates”
22 of its findings point the other way.
- 273 independent labs in 41 countries
- 22 findings against
- 107 trials, 28 with no results posted
- Funders: National Institutes of Health and others
- 46 of 602 findings with company ties
- 102 of 107 trials sponsored by developers of drugs aimed at it
- Human trial63
- Humans63
- Animals739
- Model organisms36
- Cells220
- In silico21
Interventions
45Rapamycin
downin reviews6downin silico1
7 studies
Rapamycin
downin reviews6downin silico1
Rapamycin inhibits MTOR (at ultra-low dose).
“ultra-low dose rapamycin provides mTOR inhibition”
Reviewat ultra-low doseultra-low dose
Autophagy Enhancement with Spermidine and Rapamycin Microdosing
Zenodo (CERN European Organization for Nuclear Research)Preprint
Rapamycin inhibits MTOR in silico (predicted in silico, validated against documented mechanism).
“the model correctly predicted rapamycin's inhibition of mTOR and metformin's activation of AMPK.”
In silicopredicted in silico, validated against documented mechanism
International journal of molecular sciences
Rapamycin inhibits MTOR.
“Rapamycin and its analogs (everolimus, temsirolimus, ridaforolimus) inhibit the mammalian target of rapamycin (mTOR) kinase by binding to FK506-binding proteins (FKBP)”
Review
Why Is Rapamycin Not a Rapalog?
Gerontology
Rapamycin inhibits MTOR.
“its immunosuppressant effects that are mediated by its inhibition of the mechanistic target of rapamycin (mTOR)”
Review
American journal of physiology. Endocrinology and metabolism
Rapamycin inhibits MTOR.
“targeted therapy like mTOR inhibitors such as Rapamycin and selective PI3Kδ inhibitors”
Review
An updated review on activated PI3 kinase delta syndrome (APDS)
Genes & diseases
Rapamycin inhibits MTOR.
“Rapamycin is a potent and selective inhibitor of the mechanistic target of rapamycin (mTOR) protein kinase”
Review
Inhibition of the Mechanistic Target of Rapamycin (mTOR)-Rapamycin and Beyond
Cold Spring Harbor perspectives in medicine
Rapamycin inhibits MTOR.
“By inhibiting the activity of mammalian target of rapamycin (mTOR)”
Review
Fighting neurodegeneration with rapamycin: mechanistic insights
Nature reviews. Neuroscience
Leucine
upin humans1upin mice1upin reviews1
3 studies
Leucine
upin humans1upin mice1upin reviews1
Leucine activates MTOR.
“the discovery of the unique role of leucine for the activation of the mTOR signal complex for the initiation of MPS”
Review
Impacts of protein quantity and distribution on body composition
Frontiers in nutrition
Leucine activates MTOR in humans.
“l-leucine activates TOR to initiate protein synthesis in the skeletal muscle.”
Reviewskeletal muscle
Clinical nutrition ESPEN
Leucine activates MTOR in 13-month-old mice.
“both 8 weeks of leucine supplementation and aerobic training elevated the activity of mTOR”
Animalsin 13-month-old micechow diet with 5% leucineskeletal muscle5% leucine in chow8 weeks
Nutrients
Dietary restriction
downin C. japonica2no changein rats1
3 studies
Dietary restriction
downin C. japonica2no changein rats1
Dietary restriction decreases MTOR in C. japonica (sex difference, females).
“DR downregulated mTOR expression more in females than in males.”
Animalssex difference, femalesliverfemales
Dietary restriction reveals sex-specific expression of the mTOR pathway genes in Japanese quails
Scientific reports
Dietary restriction decreases MTOR in C. japonica.
“dietary restriction led to decreased expression of mTOR and insulin-like growth factor 1 (IGF1)”
Animals2 weeks
The Journal of experimental biology
Dietary restriction showed no clear effect on MTOR in rats (IPDR and PNDR groups).
“IPDR and PNDR reduced skeletal muscle mass but did not decrease mTOR.”
AnimalsIPDR and PNDR groupsskeletal muscle
Nutrition research (New York, N.Y.)
Rapamycin analog
downin human cells1downin yeast cells1
1 study
Rapamycin analog
downin human cells1downin yeast cells1
Rapamycin analog inhibits MTOR in human cells (restricted to cells expressing mutant FKBP12).
“selective mTOR inhibition can be achieved in Saccharomyces cerevisiae and human cells”
Cellsrestricted to cells expressing mutant FKBP12
Tissue-restricted inhibition of mTOR using chemical genetics
Proceedings of the National Academy of Sciences of the United States of America
Rapamycin analog inhibits MTOR in yeast cells (restricted to cells expressing mutant FKBP12).
“selective mTOR inhibition can be achieved in Saccharomyces cerevisiae and human cells”
Cellsrestricted to cells expressing mutant FKBP12
Tissue-restricted inhibition of mTOR using chemical genetics
Proceedings of the National Academy of Sciences of the United States of America
Time-restricted feeding
upin humans1
1 study
Time-restricted feeding
upin humans1
Time-restricted feeding increases MTOR in humans (evening).
“and also increased the expression of MTOR (p = 0.007)”
Human trialeveningearly (8 am–2 pm eating window)whole blood4-dayn = 11
Nutrients
Time-restricted feeding increases MTOR in humans (9 ± 3%).
“CLOCK and PER2 were unaffected at both times of day (p ≥ 0.32). eTRF also increased levels of SIRT1 (10 ± 3%; p = 0.004) and LC3A (22 ± 5%; p = 0.001) in the morning and increased levels of MTOR (9 ± 3%; p = 0.007) in the evening.”
Human trial4 daysn = 8
Nutrients
Learning
no changein zebrafish1upin zebrafish1
1 study
Learning
no changein zebrafish1upin zebrafish1
Learning showed no clear effect on MTOR in zebrafish (young animals).
“In younger animals, this increase in activation did not occur”
Animalsyoung animalsbrain
Experimental gerontology
Learning activates MTOR in zebrafish (old animals, early phase of memory consolidation).
“TOR activation in old animals occurs in the early phase of consolidation”
Animalsold animals, early phase of memory consolidationbrain
Experimental gerontology
Safflower yellow
downin rats1
1 study
Safflower yellow
downin rats1
Safflower yellow inhibits MTOR in rats (sevoflurane-induced cognitive impairment).
“decreased p-mTOR/mTOR”
Animalssevoflurane-induced cognitive impairmenthippocampusmales
Journal of Radiation Research and Applied Sciences
Cedrus deodara flavonoids
downin mice1
1 study
Cedrus deodara flavonoids
downin mice1
Cedrus deodara flavonoids decrease MTOR in mice (gene expression measured by RT-qPCR).
“qPCR confirming upregulated Sirt1-PGC-1α and downregulated mTOR”
Animalsgene expression measured by RT-qPCRtotal flavonoid extract14 days
Research SquarePreprint
Aerobic training
upin rats1
1 study
Aerobic training
upin rats1
Aerobic training increases MTOR in rats (expression measured by qRT-PCR; regardless of age) (main effect of Exercise p < 0.001).
“mTOR expression increased with exercise regardless of age (main effect of Exercise, p < 0.001).”
Animalsexpression measured by qRT-PCR; regardless of agerunning-wheel trainingmyocardium8 weeksmalesn = 48
European journal of applied physiology
Kun-ling wan formula
downin mouse cells1
1 study
Kun-ling wan formula
downin mouse cells1
Kun-ling wan formula inhibits MTOR in mouse cells during C3H10T1/2 cell differentiation; reversible by leucine.
“KLW inhibited mTOR/S6K phosphorylation during differentiation”
Cellsduring C3H10T1/2 cell differentiation; reversible by leucine
Pharmaceuticals (Basel, Switzerland)
Aerobic exercise
downin humans1
1 study
Aerobic exercise
downin humans1
Aerobic exercise decreases MTOR in humans.
“In this study, it was found that the IFG, EXG, and IFEXG interventions all significantly reduced mTOR levels.”
Human trialtwo weeksn = 10
Sports (Basel, Switzerland)
Intermittent fasting
downin humans1
1 study
Intermittent fasting
downin humans1
Intermittent fasting decreases MTOR in humans.
“In this study, it was found that the IFG, EXG, and IFEXG interventions all significantly reduced mTOR levels.”
Human trialtwo weeksn = 10
Sports (Basel, Switzerland)
Aerobic exercise + intermittent fasting
downin humans1
1 study
Aerobic exercise + intermittent fasting
downin humans1
Aerobic exercise + intermittent fasting decreases MTOR in humans.
“When reviewing the pre–post mTOR levels of the three intervention groups, IFEXG had a greater reduction than IFG and EXG.”
Human trialtwo weeksn = 10
Sports (Basel, Switzerland)
Exercise
downin humans1
1 study
Exercise
downin humans1
Exercise decreases MTOR in humans.
“A statistically significant decrease was found in the relative abundance of mTOR (z = −2.533; p = 0.011, d = 0.58540).”
Human triallymphocytes8-weekmalesn = 9
Healthcare (Basel, Switzerland)
Collagen protein hydrolysate + milk protein
upin humans1
1 study
Collagen protein hydrolysate + milk protein
upin humans1
Collagen protein hydrolysate + milk protein activates MTOR in humans (FED leg, at 2 h).
“In the FED leg, both MP and CP+MP significantly elevated mTOR activation at 2 h (P < 0.05), with the response to CP+MP being significantly greater (P < 0.05) ( A).”
Human trialFED leg, at 2 hmalesn = 8
Clinical nutrition (Edinburgh, Scotland)
All 45Fewer
Effects
66Cellular senescence
upin human cells3is required forin human cells2upin cells1upin mice1+2
9 studies
Cellular senescence
upin human cells3is required forin human cells2upin cells1upin mice1+2
MTOR induces cellular senescence in human cells (LAM models).
“LAM models induce mTOR dependent senescence in alveolar type 2 cell organoids in vitro and in vivo.”
CellsLAM modelsalveolar type 2 cell
Nature communications
MTOR increases cellular senescence (hyperactivation of mTOR).
“hyperactivation of mTOR promotes cellular senescence and disrupts decidualization”
Reviewhyperactivation of mTORendometrium
Reproductive sciences (Thousand Oaks, Calif.)
MTOR is required for cellular senescence in human cells during establishment of the senescent state.
“This reactivation of mTOR, which is critical for establishing the senescent state”
Cellsduring establishment of the senescent statedermal fibroblast
Aging cell
MTOR increases cellular senescence in mice (shown by endothelial cell-specific deletion).
“Improvement in arterial function in old mice was concomitant with reductions in arterial cellular senescence, inflammation, and oxidative stress.”
Animalsshown by endothelial cell-specific deletionartery
Aging cell
MTOR mediates cellular senescence (cardiovascular disorders).
“we highlight the targets (SIRT1 and mTOR) that regulating cellular senescence in cardiovascular disorders”
Reviewcardiovascular disorders
Cellular Senescence in Cardiovascular Diseases: A Systematic Review
Aging and disease
MTOR is required for cellular senescence in human cells (at least partially; together with DNA-damage response signaling).
“Astrocyte senescence was at least partially depending on active mechanistic-target-of-rapamycin (mTOR) and DNA-damage response signaling”
Cellsat least partially; together with DNA-damage response signalingastrocyte
Unique signatures of stress-induced senescent human astrocytes
Experimental neurology
MTOR increases cellular senescence in cells (shown by inhibition; blocking mTOR prevented induction of senescence).
“restoration of mitophagy, either by overexpression of parkin or inhibition of mTOR, prevents mitochondrial dysfunction and induction of senescence”
Cellsshown by inhibition; blocking mTOR prevented induction of senescencecardiomyocytes
Aging cell
MTOR increases cellular senescence in human cells (shown by inhibition in OSKM-expressing primary human fibroblasts).
“mTOR inhibition blunts the induction of cyclin-dependent kinase (CDK) inhibitors (CDKIs), including p16INK4a, p21CIP1, and p15INK4b, preventing OSKM-induced senescence.”
Cellsshown by inhibition in OSKM-expressing primary human fibroblasts
Genes & development
MTOR increases cellular senescence in human cells (shown by silencing MTOR expression in the extended-passaging model).
“Rapamycin and silencing of mTOR expression inhibited replicative senescence in VSMCs”
Cellsshown by silencing MTOR expression in the extended-passaging modelvascular smooth muscle cell
The PI3K/Akt/mTOR pathway regulates the replicative senescence of human VSMCs
Molecular and cellular biochemistry
Autophagy
downin mice2downin cells1mediatesin mouse cells1downin reviews1
5 studies
Autophagy
downin mice2downin cells1mediatesin mouse cells1downin reviews1
MTOR inhibits autophagy in mice (aged mice).
“Increased mTOR expression in aged mice further suggested mTOR-driven autophagy inhibition.”
Animalsaged mice
Sex-specific effects of acetylation on tauopathy in aging htau mice
Scientific reports
MTOR mediates autophagy in mouse cells (downstream of SIRT2 in D-galactose-treated HT-22 cells).
“These effects were abolished by mTOR activation, confirming mTOR as a downstream mediator of SIRT2.”
Cellsdownstream of SIRT2 in D-galactose-treated HT-22 cells
Brain research bulletin
MTOR inhibits autophagy.
“mammalian target of rapamycin complex 1 (mTORC1) may leave anti-aging impacts by robustly inhibiting autophagy”
Review
mTOR signaling and Alzheimer's disease: What we know and where we are?
CNS neuroscience & therapeutics
MTOR inhibits autophagy in mice (mTOR overactivation in Zmpste24-/- mice; reducing mTOR partially restores autophagy).
“mTOR inhibition partially restores autophagy and S6K1 activity.”
AnimalsmTOR overactivation in Zmpste24-/- mice; reducing mTOR partially restores autophagy
Accumulation of prelamin A induces premature aging through mTOR overactivation
FASEB journal : official publication of the Federation of American Societies for Experimental Biology
MTOR inhibits autophagy in cells (via ULK1 phosphorylation at S757).
“phosphorylates ULK1 at S757 to further inactivate ULK1, LC3A and autophagy”
Cellsvia ULK1 phosphorylation at S757
Scientific reports
Lifespan
downin mice2upin flies1mediatesin reviews1−20% median survival in mtor(δ/δ) mice
4 studies
Lifespan
downin mice2upin flies1mediatesin reviews1−20% median survival in mtor(δ/δ) mice
MTOR extends lifespan in flies (overexpression in CG7156-knockdown flies).
“Overexpression of mTOR in this model improved motor function and lifespan.”
Model organismsoverexpression in CG7156-knockdown flies
Bi-allelic variants in the ribosomal protein RPS6KC1 cause a complex neurodevelopmental disorder
American journal of human genetics
MTOR shortens lifespan in mice (shown by genetic reduction in mice carrying two copies of the human LMNA G608G BAC).
“genetic reduction of the mechanistic target of rapamycin (mTOR) significantly extends lifespan in these mice”
Animalsshown by genetic reduction in mice carrying two copies of the human LMNA G608G BAC
Genetic reduction of mTOR extends lifespan in a mouse model of Hutchinson-Gilford Progeria syndrome
Aging cell
MTOR mediates lifespan under dietary restriction.
“mTOR is emerging as the most robust mediator of the protective effects of various forms of dietary restriction, which has been shown to extend lifespan and slow the onset of age-related diseases across species”
Reviewunder dietary restriction
mTOR and Aging: An Old Fashioned Dress
International journal of molecular sciences
MTOR shortens lifespan in mice (shown by hypomorphic mTOR(Δ/Δ) alleles with about 25% of wild-type expression) (approximately 20% increase in median survival in mTOR(Δ/Δ) mice).
“exhibit an approximately 20% increase in median survival”
Animalsshown by hypomorphic mTOR(Δ/Δ) alleles with about 25% of wild-type expressionhypomorphic allele
Cell reports
Senescence-associated secretory phenotype (SASP)
mediatesin cells1upin human cells1mediatesin reviews1
3 studies
Senescence-associated secretory phenotype (SASP)
mediatesin cells1upin human cells1mediatesin reviews1
MTOR mediates senescence-associated secretory phenotype (SASP) (as described in the review's mechanistic overview).
“the cGAS-STING and mTOR-driven SASP programs”
Reviewas described in the review's mechanistic overview
Multidimensional Regulatory Network of Cellular Senescence: From Mechanisms to Theranostics
ACS biomaterials science & engineering
MTOR increases senescence-associated secretory phenotype (SASP) in human cells (shown by inhibition in OSKM-expressing primary human fibroblasts).
“inhibition of mTOR blunts the senescence-associated secretory phenotype (SASP)”
Cellsshown by inhibition in OSKM-expressing primary human fibroblasts
Genes & development
MTOR mediates senescence-associated secretory phenotype (SASP) in cells (via 4EBP1-dependent translation of MAPKAPK2).
“Here we report a mechanism by which mTOR controls the SASP by differentially regulating the translation of the MK2”
Cellsvia 4EBP1-dependent translation of MAPKAPK2
mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype
Nature cell biology
TP53
upin human cells1upin mouse cells1
2 studies
TP53
upin human cells1upin mouse cells1
MTOR activates TP53 in human cells within enlarged late endosomal aggregates after cortactin depletion.
“The mTOR protein complex was accumulated and activated within these abnormal vesicular structures, leading to robust p53 activation”
Cellswithin enlarged late endosomal aggregates after cortactin depletion
bioRxiv (Cold Spring Harbor Laboratory)Preprint
MTOR activates TP53 in mouse cells (phosphorylation at serine 15).
“mTOR kinase, a major component of mTORC1 and mTORC2, directly binds p53 and phosphorylates it at serine 15.”
Cellsphosphorylation at serine 15
mTOR kinase leads to PTEN-loss-induced cellular senescence by phosphorylating p53
Oncogene
Bone mineral density
downin humans1OR 0.813–0.934
1 study
Bone mineral density
downin humans1OR 0.813–0.934
MTOR is linked with lower bone mineral density in humans (OR 0.8130-0.9340).
“increased genetically proxied mTOR expression in blood was associated with reduced BMD (OR = 0.8130-0.9340)”
Humanssummary data-based Mendelian randomization using blood cis-eQTL instruments; except individuals younger than 30 yearsblood
International journal of endocrinology
Ovariectomy-induced bone loss
downin mice1
1 study
Ovariectomy-induced bone loss
downin mice1
MTOR protects against ovariectomy-induced bone loss in mice (ovariectomy; shown by X/A-like cell-specific Mtor deletion).
“X/A-like cell-specific Mtor deletion significantly exacerbated bone loss in female mice following ovariectomy, impacting both trabecular and cortical parameters”
Animalsovariectomy; shown by X/A-like cell-specific Mtor deletionfemales
Intact mTOR signaling in gastric X/A-like cells is required for bone homeostasis
Frontiers in endocrinology
Cortical bone mass
upin mice1
1 study
Cortical bone mass
upin mice1
MTOR increases cortical bone mass in mice (shown by X/A-like cell-specific Mtor deletion).
“mTOR signaling deficiency in X/A-like cells compromises bone health in male mice, evidenced by cortical bone loss at 12 weeks”
Animalsshown by X/A-like cell-specific Mtor deletionmales
Intact mTOR signaling in gastric X/A-like cells is required for bone homeostasis
Frontiers in endocrinology
Normal liver physiology
is required forin reviews1
1 study
Normal liver physiology
is required forin reviews1
MTOR is required for normal liver physiology.
“which is essential for normal liver physiology”
Reviewliver
Experimental gerontology
Hemostasis
no changein mice1
1 study
Hemostasis
no changein mice1
MTOR showed no clear effect on hemostasis in mice (shown by knockout).
“the absence of platelet mTOR did not impact hemostasis, inflammatory bleeding in the lung and skin, or FeCl3-induced arterial thrombosis”
Animalsshown by knockout
Platelet mTOR Is a Regulator of Sterile Immunothrombosis
Arteriosclerosis, thrombosis, and vascular biology
All 66Fewer
Upstream
9AMPK signaling
downin reviews2
2 studies
AMPK signaling
downin reviews2
AMPK signaling inhibits MTOR.
“AMPK contributes to metabolic homeostasis through the inhibition of mTOR signaling”
Review
Reproductive sciences (Thousand Oaks, Calif.)
AMPK signaling inhibits MTOR.
“AMPK also suppresses mTOR, reducing age-related dysfunction.”
Review
Molecular Mechanisms of Cellular Senescence in Age-Related Endometrial Dysfunction
Cells
STAU1
upin human cells1upin mice1
1 study
STAU1
upin human cells1upin mice1
STAU1 increases MTOR in mice (shown by STAU1 reduction in BAC-C9ORF72, ATXN2Q127 and Thy1-TDP-43 transgenic mice).
“Reducing STAU1 levels in these mice normalized mTOR levels and activity and autophagy-related marker proteins.”
Animalsshown by STAU1 reduction in BAC-C9ORF72, ATXN2Q127 and Thy1-TDP-43 transgenic mice
Staufen Impairs Autophagy in Neurodegeneration
Annals of neurology
STAU1 increases MTOR in human cells (overexpression in HEK293 cells).
“Overexpression of STAU1 in HEK293 cells increased mTOR levels through direct MTOR mRNA interaction, activating downstream targets and impairing autophagic flux.”
Cellsoverexpression in HEK293 cells
Staufen Impairs Autophagy in Neurodegeneration
Annals of neurology
RS4845987
downin humans1
1 study
RS4845987
downin humans1
RS4845987 is linked with lower MTOR in humans.
“reduces MTOR expression in T cells”
HumansT cells
Nature communications
PPP4C
downin mice1
1 study
PPP4C
downin mice1
PPP4C inhibits MTOR in mice (shown by PPP4 depletion).
“depletion of PPP4 causes the abnormal activation of mTOR”
Animalsshown by PPP4 depletionoocytefemales
Cell death & disease
p38γ/δ
upin mice1
1 study
p38γ/δ
upin mice1
p38γ/δ activates MTOR in MKK6 knockout mice.
“causing MKK3-p38γ/δ hyperphosphorylation and increased mammalian target of rapamycin (mTOR) signaling”
Animalsin MKK6 knockout miceheart
MKK6 deficiency promotes cardiac dysfunction through MKK3-p38γ/δ-mTOR hyperactivation
eLife
BVR-A
downin mice1
1 study
BVR-A
downin mice1
BVR-A inhibits MTOR in mice (shown by knockout (BVR-A−/− mice)).
“BVR-A deficiency leads to the accumulation of oxidatively-damaged proteins along with mTOR hyper-activation in the cortex.”
Animalsshown by knockout (BVR-A−/− mice)cerebral cortex
Antioxidants (Basel, Switzerland)
MIR-199A-3P
downin cells1
1 study
MIR-199A-3P
downin cells1
MIR-199A-3P inhibits MTOR in cells (direct target identified by target prediction and examination).
“we identified mechanistic target of rapamycin kinase (mTOR) as a direct target of miR-199a-3p”
Cellsdirect target identified by target prediction and examination
miR-199a-3p regulates brown adipocyte differentiation through mTOR signaling pathway
Molecular and cellular endocrinology
RHEB
downin reviews1
1 study
RHEB
downin reviews1
RHEB inhibits MTOR (when not bound to GTP).
“suggesting that RHEB can function as an inhibitor of mTOR when not bound to GTP”
Reviewwhen not bound to GTP
Small GTPases in C. elegans metabolism
Small GTPases
Old tissue
upin mice1
1 study
Old tissue
upin mice1
Old tissue increases MTOR in mice (old compared with young and adult mice).
“Significant increased mTOR protein levels were determined in old tissue and cells.”
Animalsold compared with young and adult mice
Macroautophagy is impaired in old murine brain tissue as well as in senescent human fibroblasts
Redox biology
Associations
29Cellular senescence
mixedin reviews2
2 studies
Cellular senescence
mixedin reviews2
MTOR is associated with cellular senescence.
“While mechanistic target of rapamycin complex 1 is considered the master regulator of autophagy, it also influences senescence.”
Review
Orchestration of Autophagy and Senescence: Kinases Take the Center Stage
Cells
MTOR is associated with cellular senescence.
“link mTOR to various processes related to aging, such as nutrient sensing, maintenance of proteostasis, autophagy, mitochondrial dysfunction, cellular senescence, and decline in stem cell function”
Review
mTOR as a central regulator of lifespan and aging
F1000Research
Neurodegenerative disease
upin reviews1mixedin reviews1
2 studies
Neurodegenerative disease
upin reviews1mixedin reviews1
MTOR is associated with neurodegenerative disease.
“its imbalance is linked with a variety of neurodegenerative diseases”
Reviewbrain
BBA advances
MTOR is associated with neurodegenerative disease.
“mTOR forms the complexes mTOR Complex 1 and mTOR Complex 2 and can impact multiple neurodegenerative disorders that include Alzheimer's disease, Huntington's disease, and Parkinson's disease.”
Review
Biochemical Society transactions
Alzheimer's disease
upin humans1mixedin humans1
2 studies
Alzheimer's disease
upin humans1mixedin humans1
MTOR is associated with Alzheimer's disease in humans (aberrant mTOR activity in AD brains and rodent models).
“aberrant mTOR activity is one of the key events contributing to the onset and progression of AD hallmarks”
Reviewaberrant mTOR activity in AD brains and rodent modelsbrain
mTOR signaling as a molecular target for the alleviation of Alzheimer's disease pathogenesis
Neurochemistry international
MTOR is associated with Alzheimer's disease in humans.
“Aberrant regulation of mTOR occurs in the brains of patients with Alzheimer's disease and in numerous tissues of individuals with type 2 diabetes”
Reviewbrain
Mammalian Target of Rapamycin at the Crossroad Between Alzheimer's Disease and Diabetes
Advances in experimental medicine and biology
Lifespan
upin mice1mixedin reviews1
2 studies
Lifespan
upin mice1mixedin reviews1
MTOR is associated with lifespan.
“the involvement of the mTOR pathway in regulating life span and aging has been studied extensively in the last decade”
Review
mTOR as a central regulator of lifespan and aging
F1000Research
MTOR is associated with lifespan in mice (Shown by mTOR mutation; mortality parameter changes differed in direction between sexes).
“p53 mutation in Drosophila and mTOR mutation in mice caused increased median life span”
AnimalsShown by mTOR mutation; mortality parameter changes differed in direction between sexes
The journals of gerontology. Series A, Biological sciences and medical sciences
Generalized lymphatic anomaly
upin humans1
1 study
Generalized lymphatic anomaly
upin humans1
MTOR is associated with generalized lymphatic anomaly in humans (lymphatic lesion tissue).
“by immunohistochemical analysis, we documented altered expression of mTOR and its well-characterized downstream substrates”
Humanslymphatic lesion tissuelymphatic lesion
Cells
Highly ranked bridge position between aging and longevity seed sets
upin silico1
1 study
Highly ranked bridge position between aging and longevity seed sets
upin silico1
MTOR is associated with highly ranked bridge position between aging and longevity seed sets in silico (Aging-KG network topology).
“Network analyses of the Aging-KG identified TP53, mTOR, and SIRT1 as highly ranked bridge candidates between aging and longevity seed sets.”
In silicoAging-KG network topology
Scientific reports
Pentadecanoic acid
downin reviews1
1 study
Pentadecanoic acid
downin reviews1
Pentadecanoic acid is associated with MTOR (binding energy -4.4 kcal/mol versus -10.1 kcal/mol for rapamycin).
“pentadecanoic acid binds within the active site with a binding energy of -4.4 kcal/mol”
Reviewin molecular docking against the mTOR kinase domain (PDB 4JSV); weaker than rapamycin (-10.1 kcal/mol)
The Journal of steroid biochemistry and molecular biology
Basal metabolic rate
downin humans1
1 study
Basal metabolic rate
downin humans1
MTOR is associated with basal metabolic rate in humans (phenome-wide association study of mTOR-related genetic variants) (Beta = -16.769, FDR = 2.21E - 25).
“PheWAS identified an association between mTOR and basal metabolic rate (Beta = -16.769, FDR = 2.21E - 25)”
Humansphenome-wide association study of mTOR-related genetic variants
International journal of endocrinology
Chronic liver disease
no changein reviews1
1 study
Chronic liver disease
no changein reviews1
MTOR is associated with chronic liver disease.
“is also implicated in the pathogenesis of CLD and hepatocellular carcinoma (HCC)”
Reviewliver
Experimental gerontology
Venous thrombosis
upin mice1
1 study
Venous thrombosis
upin mice1
MTOR raises the risk of venous thrombosis in mice (shown by knockout).
“platelet-specific mTOR knockout mice were protected from ischemic stroke brain injury and stasis-induced venous thrombosis”
Animalsshown by knockout
Platelet mTOR Is a Regulator of Sterile Immunothrombosis
Arteriosclerosis, thrombosis, and vascular biology
All 29Fewer
Funding
92 grants since 2016National Institute on Aging$22.6MNational Cancer Institute$20.7MNational Heart, Lung, and Blood Institute$7.1M
Disentangling the role of mTOR in post-traumatic osteoarthritis
US Department of Veterans AffairsWm S. Middleton Memorial Veterans Hosp2026–2029
The Central Role of mTOR in ME/CFS Pathogenesis.
National Institute of Neurological Disorders and StrokeSimmaron Research$780K2026–2029
Pharmacokinetics (PK) and Pharmacodynamics (PD) Characterization of mTOR Inhibitors in Older Adults
National Institute on AgingUT Southwestern Medical Center$611K2024–2027
Safer mTOR inhibition for human geroprotection
National Institute on AgingUniversity of Wisconsin-madison$615K2023–2028
A chemical-genetic model for pharmacological mTOR studies across tissues and organs
NIH Office of the DirectorUniversity of California, San Francisco$451K2026–2028
National Institute on AgingUniversity of Wisconsin-madison$603K2025–2030
Energy balance, mTOR pathway signaling, and breast cancer prognosis
National Cancer InstituteOhio State University$766K2026–2028
Regulation of growth and lifespan via chromatin regulation by the nutrient-responsive factor mTORC1
Japan Society for the Promotion of ScienceHiroshima University¥4.6M2026–2029
Novel longevity enhancing pathways regulated by mTOR
National Institute on AgingDrexel University$417K2022–2027
Metabolic regulation of healthy aging by diet, mTOR signaling, and skeletal muscle
National Institute on AgingUniversity of Wisconsin-madison$85.9K2023–2029
How this record changed
Summary written from the findings.